Kymanox

Kymanox, founded in 2004, is a global life-science services firm that accelerates the design, development, and commercialization of modern medicines and therapies. Leveraging over two decades of experience, the company delivers integrated engineering, scientific, regulatory, and project-management solutions—including technical project management, process operations, CMC, advanced therapies, and FDA PAI assistance—to more than 300 clients across 20+ countries. Its distinctive value lies in a collaborative, end-to-end approach that combines deep local expertise with a relentless focus on quality, innovation, and regulatory excellence, enabling over 200 successful product launches worldwide. Kymanox's culture of partnership and patient-centric commitment drives continuous improvement in the life-science sector.